Biotech · Private company
Aston Sci. Inc.
Track this companyFree. Adds Aston Sci. Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- AST-201Phase 2 · Advanced Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- AST-301(pNGVL3-hICD)Phase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- CapecitabinePhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 2 · Advanced Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 2 · Advanced Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- rhuGM-CSFPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- rhuGM-CSF(Granulocyte-Macrophage Colony-Stimulating Factor)Phase 2 · Advanced Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian CancerPHASE2 · NOT_YET_RECRUITING · started Jun 1, 2027ClinicalTrials.gov NCT05794659 · fetched Nov 12, 2026
- Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast CancerPHASE2 · TERMINATED · started Feb 28, 2022ClinicalTrials.gov NCT05163223 · fetched Nov 12, 2026